November 24, 2020 – BURNABY, British Columbia — Symvivo Corporation, a clinical-stage biotechnology company advancing a proprietary bacTRL™ gene delivery platform, announced today that it has entered into a research… Read More
SEATTLE, Nov. 23, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced that Jonathan Drachman,… Read More
Acquisition enhances AbCellera’s ability to generate large databases of human antibodies for drug discovery programs NOVEMBER 18, 2020 – VANCOUVER, British Columbia, November 18, 2020 – AbCellera, a technology company… Read More
NOVEMBER 19, 2020 – VANCOUVER, British Columbia, and BOSTON, November 19, 2020 – AbCellera, a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that can… Read More
NOVEMBER 19, 2020 – VANCOUVER, British Columbia, November 19, 2020 – AbCellera, a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that can be developed… Read More
